Symbols

LYRA(Delisted)

Lyra Therapeutics·NASDAQ

--(--)

LYRA fundamentals

LYRA Q2 2025 Earnings

Lyra Therapeutics (LYRA) released its earnings on Aug 12, 2025: revenue was 191.50K (YoY -67.98%), missed estimates; EPS was -5.51 (YoY +85.11%), beat estimates.

Revenue / YoY

191.50K

-67.98%

EPS / YoY

-5.51

+85.11%

Report date

Aug 12, 2025

Earnings Call

4:00 PM on Aug 12, 2025

Meeting link.

Earnings

EPS

Revenue

Revenue & Expenses

LYRA has released its 2025 Q3 earnings report, with revenue of 25.00K, reflecting a YoY change of -87.18%, and net profit of -5.98M, showing a YoY change of 49.60%. The Sankey diagram below clearly presents LYRA's revenue sources and cost distribution.

Key Indicators

Lyra Therapeutics (LYRA) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Lyra Therapeutics (LYRA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Lyra Therapeutics (LYRA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Lyra Therapeutics (LYRA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Lyra Therapeutics (LYRA) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Lyra Therapeutics (LYRA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data